| ANTIROBE (25 MG)Zoetis Canada Inc · Status since Oct 2015 | 00813532 | Marketed | Zoetis Canada Inc | Oct 2015 |
| ANTIROBE (150 MG)Zoetis Canada Inc · Status since Apr 2016 | 00813524 | Marketed | Zoetis Canada Inc | Apr 2016 |
| ANTIROBE (75 MG)Zoetis Canada Inc · Status since Oct 2015 | 00813540 | Marketed | Zoetis Canada Inc | Oct 2015 |
| AURO-CLINDAMYCIN (150 MG)Auro Pharma Inc. · Status since Mar 2015 | 02436906 | Marketed | Auro Pharma Inc. | Mar 2015 |
| AURO-CLINDAMYCIN (300 MG)Auro Pharma Inc. · Status since Mar 2015 | 02436914 | Marketed | Auro Pharma Inc. | Mar 2015 |
| BENZACLIN (1 %)Bausch Health, Canada Inc. · Status since Mar 2021 | 02248472 | Marketed | Bausch Health, Canada Inc. | Mar 2021 |
| CLINACIN (25 MG)Chanelle Pharmaceuticals Manufacturing Limited · Status since Sep 2006 | 02277719 | Marketed | Chanelle Pharmaceuticals Manufacturing Limited | Sep 2006 |
| CLINACIN (75 MG)Chanelle Pharmaceuticals Manufacturing Limited · Status since Sep 2006 | 02277727 | Marketed | Chanelle Pharmaceuticals Manufacturing Limited | Sep 2006 |
| CLINACIN (150 MG)Chanelle Pharmaceuticals Manufacturing Limited · Status since Sep 2006 | 02277735 | Marketed | Chanelle Pharmaceuticals Manufacturing Limited | Sep 2006 |
| CLINACIN SOLUTION (25 MG)Chanelle Pharmaceuticals Manufacturing Limited · Status since Jul 2016 | 02419459 | Marketed | Chanelle Pharmaceuticals Manufacturing Limited | Jul 2016 |
| CLINDAMYCIN (150 MG)Sanis Health Inc. · Status since Feb 2022 | 02400529 | Marketed | Sanis Health Inc. | Feb 2022 |
| CLINDAMYCIN (300 MG)Sanis Health Inc. · Status since Feb 2022 | 02400537 | Marketed | Sanis Health Inc. | Feb 2022 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE (600 MG)Baxter Corporation · Status since Nov 2019 | 02485478 | Marketed | Baxter Corporation | Nov 2019 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE (900 MG)Baxter Corporation · Status since Dec 2019 | 02485486 | Marketed | Baxter Corporation | Dec 2019 |
| CLINDAMYCIN INJECTION USP (150 MG)Sandoz Canada Inc. · Status since Aug 2005 | 02230535 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| CLINDAMYCIN INJECTION USP (150 MG)Sandoz Canada Inc. · Status since Aug 2005 | 02230540 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| CLINDAMYCIN IV INFUSION (12 MG)Sandoz Canada Inc. · Status since Dec 2013 | 02408511 | Marketed | Sandoz Canada Inc. | Dec 2013 |
| CLINDAMYCIN IV INFUSION (18 MG)Sandoz Canada Inc. · Status since Dec 2013 | 02408538 | Marketed | Sandoz Canada Inc. | Dec 2013 |
| CLINDOXYL ADV GEL (1 %)Glaxosmithkline Inc · Status since Aug 2013 | 02382822 | Marketed | Glaxosmithkline Inc | Aug 2013 |
| JAMP CLINDAMYCIN (150 MG)JAMP Pharma Corporation · Status since Sep 2019 | 02483734 | Marketed | JAMP Pharma Corporation | Sep 2019 |
| JAMP CLINDAMYCIN (300 MG)JAMP Pharma Corporation · Status since Sep 2019 | 02483742 | Marketed | JAMP Pharma Corporation | Sep 2019 |
| JAMP CLINDAMYCIN CAPSULES (150 MG)JAMP Pharma Corporation · Status since Jul 2026 | 02557878 | Marketed | JAMP Pharma Corporation | Jul 2026 |
| JAMP CLINDAMYCIN CAPSULES (300 MG)JAMP Pharma Corporation · Status since Jul 2026 | 02557886 | Marketed | JAMP Pharma Corporation | Jul 2026 |
| M-CLINDAMYCIN (150 MG)Mantra Pharma Inc. · Status since May 2019 | 02479923 | Marketed | Mantra Pharma Inc. | May 2019 |
| M-CLINDAMYCIN (300 MG)Mantra Pharma Inc. · Status since May 2019 | 02479931 | Marketed | Mantra Pharma Inc. | May 2019 |
| MED-CLINDAMYCIN (150 MG)Generic Medical Partners Inc · Status since Dec 2021 | 02462656 | Marketed | Generic Medical Partners Inc | Dec 2021 |
| MED-CLINDAMYCIN (300 MG)Generic Medical Partners Inc · Status since Dec 2021 | 02462664 | Marketed | Generic Medical Partners Inc | Dec 2021 |
| NRA-CLINDAMYCIN (150 MG)Nora Pharma Inc. · Status since Jul 2020 | 02493748 | Marketed | Nora Pharma Inc. | Jul 2020 |
| NRA-CLINDAMYCIN (300 MG)Nora Pharma Inc. · Status since Jul 2020 | 02493756 | Marketed | Nora Pharma Inc. | Jul 2020 |
| NV-CLINDAMYCIN (150 MG)Teva Canada Limited · Status since Jul 2014 | 02245832 | Marketed | Teva Canada Limited | Jul 2014 |
| RIVA-CLINDAMYCIN (300 MG)Laboratoire Riva Inc. · Status since Oct 2017 | 02468484 | Marketed | Laboratoire Riva Inc. | Oct 2017 |
| TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT (1 %)Taro Pharmaceuticals Inc · Status since Jul 2017 | 02464519 | Marketed | Taro Pharmaceuticals Inc | Jul 2017 |
| TARO-CLINDAMYCIN (1 %)Taro Pharmaceuticals Inc · Status since Oct 2005 | 02266938 | Marketed | Taro Pharmaceuticals Inc | Oct 2005 |
| TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL (1 %)Taro Pharmaceuticals Inc · Status since Aug 2015 | 02440180 | Marketed | Taro Pharmaceuticals Inc | Aug 2015 |
| TEVA-CLINDAMYCIN (150 MG)Teva Canada Limited · Status since Jan 2011 | 02241709 | Marketed | Teva Canada Limited | Jan 2011 |
| TEVA-CLINDAMYCIN (300 MG)Teva Canada Limited · Status since Jan 2011 | 02241710 | Marketed | Teva Canada Limited | Jan 2011 |
| AG-CLINDAMYCIN (150 MG)Angita Pharma Inc. · Status since Jul 2022 | 02485109 | Dormant | Angita Pharma Inc. | Jul 2022 |
| AG-CLINDAMYCIN (300 MG)Angita Pharma Inc. · Status since Jul 2022 | 02485117 | Dormant | Angita Pharma Inc. | Jul 2022 |
| ANTIROBE AQUADROPS (25 MG)Zoetis Canada Inc · Status since Jul 2024 | 00813575 | Dormant | Zoetis Canada Inc | Jul 2024 |
| CLINDA-T (1 %)Bausch Health, Canada Inc. · Status since Mar 2021 | 02243659 | Dormant | Bausch Health, Canada Inc. | Mar 2021 |
| CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP (1 %)Hikma Canada Limited · Status since Oct 2022 | 02483769 | Dormant | Hikma Canada Limited | Oct 2022 |
| NV-CLINDAMYCIN (25 MG)Teva Canada Limited · Status since Jul 2018 | 02245830 | Dormant | Teva Canada Limited | Jul 2018 |
| NV-CLINDAMYCIN (75 MG)Teva Canada Limited · Status since Jul 2018 | 02245831 | Dormant | Teva Canada Limited | Jul 2018 |
| RIVA-CLINDAMYCIN (150 MG)Laboratoire Riva Inc. · Status since Jul 2025 | 02468476 | Dormant | Laboratoire Riva Inc. | Jul 2025 |
| TARO-CLINDAMYCIN (150 MG)Sun Pharma Canada Inc. · Status since Jun 2022 | 02391643 | Approved | Sun Pharma Canada Inc. | Jun 2022 |
| TARO-CLINDAMYCIN (300 MG)Sun Pharma Canada Inc. · Status since Jun 2022 | 02391651 | Approved | Sun Pharma Canada Inc. | Jun 2022 |
| APO-CLINDAMYCIN (150 MG)Apotex Inc. · Status since Apr 2025 | 02245232 | Cancelled Post Market | Apotex Inc. | Apr 2025 |
| APO-CLINDAMYCIN (300 MG)Apotex Inc. · Status since Apr 2025 | 02245233 | Cancelled Post Market | Apotex Inc. | Apr 2025 |
| AVA-CLINDAMYCIN (150 MG)Avanstra Inc · Status since Aug 2014 | 02364719 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-CLINDAMYCIN (300 MG)Avanstra Inc · Status since Aug 2014 | 02364727 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE (300 MG)Baxter Corporation · Status since Mar 2023 | 02485451 | Cancelled Post Market | Baxter Corporation | Mar 2023 |
| CLINDAMYCIN INJECTION SDZ (150 MG)Sandoz Canada Inc. · Status since Aug 2018 | 02385716 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2018 |
| CLINDAMYCIN INJECTION, USP (150 MG)Abbott Laboratories Co. · Status since Jul 2007 | 02130866 | Cancelled Post Market | Abbott Laboratories Co. | Jul 2007 |
| CLINDAMYCIN INJECTION, USP (150 MG)Fresenius Kabi Canada Ltd · Status since Aug 2024 | 02139286 | Cancelled Post Market | Fresenius Kabi Canada Ltd | Aug 2024 |
| CLINDAMYCIN INJECTION, USP (150 MG)Mylan Pharmaceuticals Ulc · Status since Feb 2018 | 02440091 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2018 |
| CLINDAMYCIN IV INFUSION (6 MG)Sandoz Canada Inc. · Status since Apr 2021 | 02408503 | Cancelled Pre Market | Sandoz Canada Inc. | Apr 2021 |
| CLINDAMYCINE-150 (150 MG)Pro Doc Limitee · Status since Mar 2020 | 02248525 | Cancelled Post Market | Pro Doc Limitee | Mar 2020 |
| CLINDAMYCINE-300 (300 MG)Pro Doc Limitee · Status since Mar 2020 | 02248526 | Cancelled Post Market | Pro Doc Limitee | Mar 2020 |
| CLINDASOL (1.0 %)Glaxosmithkline Inc · Status since Oct 2013 | 02242970 | Cancelled Post Market | Glaxosmithkline Inc | Oct 2013 |
| CLINDETS (1 %)Glaxosmithkline Inc · Status since Sep 2017 | 02243050 | Cancelled Post Market | Glaxosmithkline Inc | Sep 2017 |
| CLINDOXYL GEL (1 %)Glaxosmithkline Inc · Status since Nov 2025 | 02243158 | Cancelled Post Market | Glaxosmithkline Inc | Nov 2025 |
| DALACIN C 150 MG (150 MG)Pfizer Canada Ulc · Status since Oct 2024 | 00030570 | Cancelled Post Market | Pfizer Canada Ulc | Oct 2024 |
| DALACIN C 300 MG (300 MG)Pfizer Canada Ulc · Status since Oct 2024 | 02182866 | Cancelled Post Market | Pfizer Canada Ulc | Oct 2024 |
| DALACIN C PHOSPHATE (150 MG)Pfizer Canada Ulc · Status since Jun 2026 | 00260436 | Cancelled Post Market | Pfizer Canada Ulc | Jun 2026 |
| DALACIN T 1% (1 %)Pfizer Canada Ulc · Status since Dec 2021 | 00582301 | Cancelled Post Market | Pfizer Canada Ulc | Dec 2021 |
| DALACIN VAGINAL CREAM (20 MG)Pfizer Canada Ulc · Status since Jun 2026 | 02060604 | Cancelled Post Market | Pfizer Canada Ulc | Jun 2026 |
| MYLAN-CLINDAMYCIN (150 MG)Mylan Pharmaceuticals Ulc · Status since Jul 2018 | 02258331 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| MYLAN-CLINDAMYCIN (300 MG)Mylan Pharmaceuticals Ulc · Status since Jul 2018 | 02258358 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| NU-CLINDAMYCIN (150 MG)Nu-Pharm Inc · Status since Mar 2018 | 02336235 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-CLINDAMYCIN (300 MG)Nu-Pharm Inc · Status since Mar 2018 | 02336243 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| PMS-CLINDAMYCIN (150 MG)Pharmascience Inc. · Status since Oct 2016 | 02294826 | Cancelled Post Market | Pharmascience Inc. | Oct 2016 |
| PMS-CLINDAMYCIN (300 MG)Pharmascience Inc. · Status since Oct 2016 | 02294834 | Cancelled Post Market | Pharmascience Inc. | Oct 2016 |
| PRIVA-CLINDAMYCIN (150 MG)Pharmapar Inc. · Status since Jul 2022 | 02503514 | Cancelled Pre Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-CLINDAMYCIN (300 MG)Pharmapar Inc. · Status since Jul 2022 | 02503522 | Cancelled Pre Market | Pharmapar Inc. | Jul 2022 |
| RATIO-CLINDAMYCIN CAPSULES - 300MG (300 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Aug 2010 | 02192659 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Aug 2010 |
| RATIO-CLINDAMYCIN CAPSULES-150MG (150 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Aug 2010 | 02130033 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Aug 2010 |
| RIVA-CLINDAMYCIN (150 MG)Laboratoire Riva Inc. · Status since Jul 2013 | 02242409 | Cancelled Post Market | Laboratoire Riva Inc. | Jul 2013 |
| RIVA-CLINDAMYCIN (300 MG)Laboratoire Riva Inc. · Status since Jul 2013 | 02242410 | Cancelled Post Market | Laboratoire Riva Inc. | Jul 2013 |
| RIVA-CLINDAMYCIN (150 MG)Laboratoire Riva Inc. · Status since May 2016 | 02293382 | Cancelled Post Market | Laboratoire Riva Inc. | May 2016 |
| RIVA-CLINDAMYCIN (300 MG)Laboratoire Riva Inc. · Status since May 2016 | 02293390 | Cancelled Post Market | Laboratoire Riva Inc. | May 2016 |